Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Association For The Treatment Of Tobacco Use And Dependence Supports The FDA Ban Of 'Electronic' Cigarettes
The

Donate Your Old Jewellery For A Good Cause, Diabetes UK
Diabetes UK is asking you to donate your unwanted or broken jewellery and accessories to our jewellery appeal.
News of the day
Landmark Five-Year African Study Indicates That HIV Therapy May Be Given Safely In Re-Limited Settings Without Routine Laboratory Monitoring
Gilead Sciences, Inc. (Nasdaq:GILD) highlighted results from a study known as DART (Development of Anti-Retroviral Treatment in Africa), which evaluated the need for routine laboratory monitoring in adults taking antiretroviral therapy in Africa. The DART trial was an open-label, randomized study comparing clinical and laboratory monitoring to clinical monitoring alone for efficacy and toxicity. In this study, 74 percent of patients were on a treatment regimen containing Viread® (tenofovir disoproxil fumarate). At baseline, more than 50 percent of patients had reduced renal function. The results indicated that Viread was well tolerated and that the incidence of renal adverse events was low. DART researchers concluded that renal function test results were similar in both arms of the trial for up to five years, suggesting that routine monitoring of Viread may not be necessary in re-limited settings when using the product as part of a first-line HIV treatment regimen. The results of the study were presented today at the 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2009) in Cape Town, South Africa.
Mental Health

Pomegranate For Prostate Cancer

Pomegranate juice may be beneficial in men who have undergone standard treatment for localized prostate cancer, according to a long-term study presented at the 104th Annual Scientific Meeting of the American Urological Association. The study, which began in 2003, included 48 men older than age 60 who underwent surgery or radiation therapy to treat localized prostate cancer. All of the men had rising prostate specific antigen (PSA) levels after treatment. PSA is an enzyme that helps break down proteins in the seminal fluid and plays an important role in fertility. Prostate cancer patients often have increased PSA levels, although cancer may occur with any PSA level. Participants drank eight ounces of pomegranate juice daily. During the six-year follow-up, men who continued drinking pomegranate juice had lower PSA levels than those who stopped drinking the juice and were no longer active in the trial. By the end of the study, it took about four times longer for active participants" PSA levels to double than it had at the beginning of the study. References 1. American Urological Association.http://www.auanet.org 2. Natural Standard: The Authority on Integrative Medicine. http://www.naturalstandard.com. Copyright © 2009. 3. Pantuck A, Zomorodian N, Rettig M, et al. Long term follow up of phase 2 study of pomegranate juice for men with prostate cancer shows durable prolongation of PSA doubling time. J Urol, suppl. 2009: 181, 4, abstract 826. Natural Standard


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009